{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_names_stdName in Standardized Name (approximate match)
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2023
Source:
Joint health by XIAN CHIANG COMPANY LIMITED
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
GOHIBIC by InflaRx GmbH
(2023)
Source URL:
First approved in 2023
Source:
GOHIBIC by InflaRx GmbH
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Sotrovimab by GlaxoSmithKline LLC
(2021)
Source URL:
First approved in 2021
Source:
Sotrovimab by GlaxoSmithKline LLC
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
BLA761158
(2020)
Source URL:
First approved in 2020
Source:
BLA761158
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Menopur by Ferring Pharmaceuticals [Canada]
Source URL:
First approved in 2016
Source:
NADA141431
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
BLA101069
(1971)
Source URL:
First approved in 1971
Source:
BLA101069
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Other
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2017)
Source URL:
First approved in 2017
Source:
21 CFR 348
Source URL:
Class:
POLYMER
